The Daily Signal
Comics

Mahershala Ali Waits Seven Years While Marvel Decides If Blade Exists

Mack·Sunday, July 26, 2026 Edition
When Assets Become Alibis

Mahershala Ali's Blade casting announcement came in July 2016. Seven years later the project remains frozen with no director, no script in active development, and no indication Marvel knows what kind of film it wants to make.

The studio has cycled through multiple creative leads and abandoned previous directions so thoroughly that Ali's attachment—once Marvel's signal of seriousness—now reads as a liability. No one is moving because everyone is waiting for someone else to know what this thing actually is.

Marvel experienced an identical paralysis with Doctor Strange. In 2007 the studio optioned the property and cast Benedict Cumberbatch in 2014—for nine years the project languished without directorial vision because Marvel's leadership couldn't agree on whether Strange was a mystical procedural, a cosmic adventure, or a philosophical meditation on ego and the self.

When attachment becomes a waiting room

Cumberbatch remained attached while the studio cycled through at least three fundamentally different creative approaches. The development didn't break until 2015, when Marvel accepted that the earlier work was worthless and Scott Derrickson arrived with clarity about tone and visual language. Only then did production accelerate, and the film released in 2016. Both Blade and Doctor Strange began with A-list actor attachment before creative clarity existed—both operated under the assumption that the actor's presence would eventually attract a director with strong vision. Both were wrong.

An attached star doesn't accelerate pre-production when the studio disagrees about the thing being produced.

What actually happened was that the actor remained available for years while Marvel's internal disagreement about the material's identity deepened. An attached star doesn't accelerate pre-production when the studio disagrees about the thing being produced—the actor becomes the waiting room's furniture. Blade differs in one specific way. Marvel's pre-production pipeline has contracted since the Doctor Strange years. The studio is now in open retreat from the creative expansion that defined 2015-2019. Ali may not be waiting for a director to arrive with vision—he may be waiting for Marvel to decide whether it still wants to make this film at all. When you keep an asset attached while you stall on commitment, you're not preserving optionality, you're making it easier to give up later without admitting you already had.

Related Stories
Culture
Nate Amos Traded Anonymous Compulsion for Accountable Compulsion
Musician Nate Amos (This Is Lorelei) replaced substance addiction with compulsive creation, then public sobriety—discovering that recovery within the creator ec
Science
States Reclassify Disabled People to Cut Medicaid Costs
Since 2010, states have systematically reclassified thousands of people with documented intellectual disabilities into cheaper diagnostic categories like 'behav
Film
Victim Families Fought Perpetrator-Centered Crime Narratives Since 1990s
Michael Mann's Manhunter frames crime cinema as 'cultural anthropology' that demands empathy for perpetrators, but victim advocacy organizations like Justice fo
More From Today's Edition
Technology
Apple's Price Hike Was 2.3 Times the Component Cost
When input costs rise industry-wide, companies can't easily distinguish real cost increases from profitable margin expansion, because competitors all claim iden
Film
Chuck Russell Made Horror Franchises Worth $40 Million
Chuck Russell didn't just direct successful horror films—he proved to Hollywood studios that horror-comedy hybrids could be expensive, family-friendly blockbust
View Past Editions >
It's Officially the End of an Era for Marvel's Blade Movie — The Daily Signal